Literature DB >> 19853005

Studies on the hippocampal formation: From basic development to clinical applications: Studies on schizophrenia.

Robert Freedman1, Dan Goldowitz.   

Abstract

The hippocampal formation plays a critical role in cognitive function. The developmental events that shape the hippocampal formation are continuing to be elucidated and their implications for brain function are emerging as well as applying those advances to interventions that have important possibilities for the treatment of brain dysfunction. The story told in this chapter is about the use of the in oculo transplant method to illuminate intrinsic and extrinsic features that underlie the development of the dentate gyrus and adjacent hippocampus and the role of one molecule in the hippocampus and schizophrenia. Schizophrenia, originally conceptualized as a dysfunction in dopaminergic neurotransmission, is now known to involve multiple neuronal systems. Dysfunction of hippocampal neurons is emerging as one of its signature pathological features. Basic insights into the development and function of hippocampal interneurons form the basis of a new treatment initiative for this illness. Evidence for the role of the alpha 7-nicotinic acetylcholine receptor in the development and function of these neurons in rodents has led to human trials of nicotinic agonists for cognitive dysfunction in schizophrenia and the possibility of improving hippocampal development in children at risk for schizophrenia by perinatal supplementation with choline, which can act as an alpha 7-nicotinic acetylcholine receptor agonist. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853005      PMCID: PMC2829353          DOI: 10.1016/j.pneurobio.2009.10.008

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  82 in total

1.  Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development.

Authors:  S Akbarian; A Viñuela; J J Kim; S G Potkin; W E Bunney; E G Jones
Journal:  Arch Gen Psychiatry       Date:  1993-03

2.  Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression.

Authors:  R Freedman; C Wetmore; I Strömberg; S Leonard; L Olson
Journal:  J Neurosci       Date:  1993-05       Impact factor: 6.167

3.  Sensory gating deficits in schizophrenia: new results.

Authors:  L L Judd; L McAdams; B Budnick; D L Braff
Journal:  Am J Psychiatry       Date:  1992-04       Impact factor: 18.112

4.  Reduced GABA uptake sites in the temporal lobe in schizophrenia.

Authors:  M D Simpson; P Slater; J F Deakin; M C Royston; W J Skan
Journal:  Neurosci Lett       Date:  1989-12-15       Impact factor: 3.046

5.  Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both.

Authors:  W H Meck; R A Smith; C L Williams
Journal:  Behav Neurosci       Date:  1989-12       Impact factor: 1.912

6.  Cholinergic gating of response to auditory stimuli in rat hippocampus.

Authors:  V Luntz-Leybman; P C Bickford; R Freedman
Journal:  Brain Res       Date:  1992-07-31       Impact factor: 3.252

7.  Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics.

Authors:  M D Browning; E M Dudek; J L Rapier; S Leonard; R Freedman
Journal:  Biol Psychiatry       Date:  1993-10-15       Impact factor: 13.382

8.  Normalization of auditory physiology by cigarette smoking in schizophrenic patients.

Authors:  L E Adler; L D Hoffer; A Wiser; R Freedman
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

9.  Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium.

Authors:  P Séguéla; J Wadiche; K Dineley-Miller; J A Dani; J W Patrick
Journal:  J Neurosci       Date:  1993-02       Impact factor: 6.167

10.  Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes.

Authors:  M Alkondon; E X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

View more
  16 in total

1.  Endogenous activation of nAChRs and NMDA receptors contributes to the excitability of CA1 stratum radiatum interneurons in rat hippocampal slices: effects of kynurenic acid.

Authors:  Manickavasagom Alkondon; Edna F R Pereira; Edson X Albuquerque
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

2.  Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.

Authors:  Hong Lin; Fu-Chun Hsu; Bailey H Baumann; Douglas A Coulter; Stewart A Anderson; David R Lynch
Journal:  Mol Cell Neurosci       Date:  2014-06-28       Impact factor: 4.314

3.  Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid.

Authors:  Jyotirmoy Banerjee; Manickavasagom Alkondon; Edna F R Pereira; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2012-02-17       Impact factor: 4.030

4.  Hippocampal shape abnormalities of patients with childhood-onset schizophrenia and their unaffected siblings.

Authors:  Sarah L M Johnson; Lei Wang; Kathryn I Alpert; Deanna Greenstein; Liv Clasen; Francois Lalonde; Rachel Miller; Judith Rapoport; Nitin Gogtay
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-04-03       Impact factor: 8.829

Review 5.  Modeling Psychiatric Disorder Biology with Stem Cells.

Authors:  Debamitra Das; Kyra Feuer; Marah Wahbeh; Dimitrios Avramopoulos
Journal:  Curr Psychiatry Rep       Date:  2020-04-21       Impact factor: 5.285

6.  Cortical thickness, gray matter volume, and white matter anisotropy and diffusivity in schizophrenia.

Authors:  Mizuho Murakami; Hidemasa Takao; Osamu Abe; Hidenori Yamasue; Hiroki Sasaki; Wataru Gonoi; Yosuke Takano; Kunio Takei; Kiyoto Kasai; Kuni Ohtomo
Journal:  Neuroradiology       Date:  2011-01-07       Impact factor: 2.804

7.  The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.

Authors:  Mei Huang; Anna R Felix; Dorothy G Flood; Chaya Bhuvaneswaran; Dana Hilt; Gerhard Koenig; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

8.  No association between polymorphisms of WNT2 and schizophrenia in a Korean population.

Authors:  Hak-Jae Kim; Jin Kyung Park; Su Kang Kim; Sung Wook Kang; Jong Woo Kim; Hyun-Kyung Park; Ah-Rang Cho; Ji Young Song; Joo-Ho Chung
Journal:  BMC Med Genet       Date:  2010-05-24       Impact factor: 2.103

Review 9.  Fragmentation and unpredictability of early-life experience in mental disorders.

Authors:  Tallie Z Baram; Elysia P Davis; Andre Obenaus; Curt A Sandman; Steven L Small; Ana Solodkin; Hal Stern
Journal:  Am J Psychiatry       Date:  2012-09       Impact factor: 18.112

Review 10.  The effect of α7 nicotinic receptor activation on glutamatergic transmission in the hippocampus.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.